GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SINTX Technologies SINT · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.54

-1.28%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About SINTX Technologies

From its filings with the US Securities and Exchange Commission

SEC filings

SINTX Technologies is based in Salt Lake City, Utah and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker SINT. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $1.0m and a net loss of $10.4m. At that date it held total assets of $9.5m and shareholders' equity of $2.9m. By business, Product [Member] brought in 71.6% of revenue, followed by Grant and Contract [Member] at 28.4%.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
11 Feb 2014
Employees
32
Website
amedica.com ↗
Head office
1885 WEST 2100 STREET, SALT LAKE CITY, UT, 84119
Incorporated in
DE
Classification
Surgical & Medical Instruments & Apparatus
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Eric OlsonChairman of the Board, President, Chief Executive Officer, since 2012$194,594
  • Mr. Kevin TraskChief Financial Officer
  • Dr. Ryan BockChief Technology Officer
  • Mr. Gregg HonigblumChief Investment Officer, Director, since 2006
  • Mr. Mark AndersonDirector
  • Mr. Chris LyonsDirector
  • Mr. Robert MitchellDirector
  • Mr. Jay MoyesDirector, since 2012$1.9m

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • SINTX Technologies operates as a commercial biomaterial company with 32 employees in Salt Lake City.
  • The company is vertically integrated in silicon nitride orthopedic medical device manufacturing.
  • SINTX focuses on silicon nitride ceramic technology for medical devices in the US and Europe.

Weaknesses

  • SINTX Technologies has only 32 employees, which may limit operational capacity.
  • The company's products are limited to the US, Europe, and South America markets.
  • SINTX's IPO in 2014 may indicate limited financial growth potential.

Opportunities

  • SINTX can expand silicon nitride technology into new medical device applications.
  • The company can grow in the European market with its orthopedic medical devices.
  • SINTX may develop additional wear- and corrosion-resistant implant components.

Threats

  • SINTX faces competition from other biomaterial companies in the Health Care sector.
  • The company's reliance on silicon nitride technology could be disrupted by new materials.
  • SINTX's limited market presence in South America may hinder global expansion.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.